Cargando…
Low-energy amplitude-modulated radiofrequency electromagnetic fields as a systemic treatment for cancer: Review and proposed mechanisms of action
Exposure to Low-Energy Amplitude-Modulated Radiofrequency Electromagnetic Fields (LEAMRFEMF) represents a new treatment option for patients with advanced hepatocellular carcinoma (AHCC). We focus on two medical devices that modulate the amplitude of a 27.12 MHz carrier wave to generate envelope wave...
Autores principales: | Tuszynski, Jack A., Costa, Frederico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498185/ https://www.ncbi.nlm.nih.gov/pubmed/36157082 http://dx.doi.org/10.3389/fmedt.2022.869155 |
Ejemplares similares
-
Low‐energy amplitude‐modulated electromagnetic field exposure: Feasibility study in patients with hepatocellular carcinoma
por: Capareli, Fernanda, et al.
Publicado: (2023) -
Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies
por: Zimmerman, Jacquelyn W., et al.
Publicado: (2013) -
Case Report: Endoscopic radiofrequency ablation with radial-EBUS and ROSE
por: Zarogoulidis, Paul, et al.
Publicado: (2023) -
Near-Infrared Photobiomodulation of Living Cells, Tubulin, and Microtubules In Vitro
por: Staelens, Michael, et al.
Publicado: (2022) -
Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields
por: Costa, F P, et al.
Publicado: (2011)